Outcomes of COVID-19 Patients under Cytotoxic Cancer Chemotherapy in Brazil

SIMPLE SUMMARY: Cancer patients present a distinct vulnerability to COVID-19. It is unclear if chemotherapy per se increases the overall risk in this population. In our study, we analyzed retrospective COVID-19 data linked to oncological information systems to evaluate outcomes in COVID-19 cancer pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Duarte, Mateus Bringel Oliveira, Leal, Frederico, Argenton, Juliana Luz Passos, Carvalheira, José Barreto Campello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760330/
https://www.ncbi.nlm.nih.gov/pubmed/33255220
http://dx.doi.org/10.3390/cancers12123490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760330/
https://www.ncbi.nlm.nih.gov/pubmed/33255220
http://dx.doi.org/10.3390/cancers12123490

Ejemplares similares